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Background: This study aimed to explore barriers to and enablers for future implementation of a draft clinical
pathway for anxiety and depression in cancer patients in the Australian context.
Methods: Health professionals reviewed a draft clinical pathway and participated in qualitative interviews about the
delivery of psychosocial care in their setting, individual components of the draft pathway, and barriers and enablers
for its future implementation.
Results: Five interrelated themes were identified: ownership; resources and responsibility; education and training;
patient reluctance; and integration with health services beyond oncology.
Conclusions: The five themes were perceived as both barriers and enablers and provide a basis for an
implementation plan that includes strategies to overcome barriers. The next steps are to design and deliver the
clinical pathway with specific implementation strategies that address team ownership, endorsement by leaders,
education and training modules designed for health professionals and patients and identify ways to integrate the
pathway into existing cancer services.
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High rates of psychological morbidity in cancer patients
and their caregivers have been well documented over the
past three decades [1-4]. The benefits of routine screening
for distress [5,6] in the cancer setting is being debated
internationally due to the considerable time and costs
associated with such screening [7]. Screening is unlikely to
be routinely implemented without compelling evidence
that it results in improved patient outcomes.
A review of intervention trials evaluating distress screen-
ing reported benefits in 17 of 24 studies; these benefits
were primarily restricted to improved communication and* Correspondence: nicole.rankin@ctc.usyd.edu.au
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unless otherwise stated.referral for psychosocial help with only six of 14 rando-
mised trials reporting benefits to patient well-being [8].
The most significant barrier to screening was the
provision of appropriate after-care; only one in three
patients received treatment after a positive screen for
distress [8]. It appears that in isolation, screening for
distress is not sufficient to impact on patient outcomes
[9,10] and currently screening is primarily implemented
for research purposes [11].
Clinical pathways are used across many health condi-
tions and are one strategy that could improve screening
and after-care appropriate to the patient’s anxiety or
depression. Pathways have shown success in bringingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Sample demographics
Professional group N = 12 Clinical experience
[years]
Medical Psychiatrist 2 20, 25
Medical oncologist 1 5
Palliative care physician 1 20
General practitioner 1 25
Allied health &
nursing
Psychologist 2 3, 6
Social worker 2 12, 33
Oncology nursing 2 23, 25
Palliative care nursing 1 15
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context and implementation [12,13]. Relatively few
pathways have been developed to deal with psycho-
logical distress following cancer diagnosis [14,15] and
these do not include explicit strategies or tools to
address barriers and encourage uptake. Evidence based
interventions for physical symptoms, such as managing
pain and breathlessness (dyspnoea) in cancer patients,
are also in development [16,17].
Conducting a barrier and enabler analysis is a precur-
sor step to designing implementation strategies [18,19].
Documented barriers and enablers to implementing clin-
ical pathways outside cancer settings [20-22] highlight
the lack of: resources; education and training; support
from leaders; and patient reluctance to accept help or poor
uptake [23]. The most recent Cochrane Review of tailored
interventions to overcome identified barriers to changing
practice highlights that research is yet to establish the
most effective ways to identify barriers, which are the most
important to address, or how to select interventions to
overcome them [24]. The aim of this paper is to explore
the most significant barriers and enablers from the
perspective of health care providers for the implementa-
tion of a draft clinical pathway for anxiety and depression
in cancer patients in the Australian context.
Methods
Participants
Medical, nursing and allied health professionals with
extensive clinical experience were purposively sampled
across multiple disciplines from the membership of the
Australian Psycho-Oncology Co-operative Research Group
[PoCoG], a national network of clinicians and researchers
interested in psycho-oncology.
Potential participants were emailed an invitation and
provided with an information statement and consent
form [which they were asked to email back] and the
draft clinical pathway document. Ethics approval was
obtained from the Sydney Local Health District Human
Research Ethics Committee [X12-0301].
Procedure and data collection
A draft evidence-based clinical pathway for managing
anxiety and depression in cancer patients tailored to the
Australian setting was developed prior to the interviews
and is described elsewhere [25]. A semi-structured quali-
tative interview schedule was developed and was open-
ended and exploratory in nature. The interview was
designed to seek health professional’s views about the
pathway elements, where these professionals represented
stakeholder groups who would be future implementers
of the pathway in clinical practice. Consenting partici-
pants reviewed the draft pathway prior to participating
in the semi-structured interview and questions focusedon the delivery of psychosocial care in their setting,
individual components of the pathway, and barriers and
enablers for its implementation. Interviews were con-
ducted face-to-face or by telephone, audio recorded and
transcribed verbatim, with recruitment ongoing until no
new themes emerged over three consecutive interviews
[theoretical saturation].
Analysis
A thematic analysis was conducted. The first six tran-
scripts were reviewed and discussed by three authors
(NR, TR, PB) and a draft coding frame was developed
and refined, with differences resolved through consensus.
The final coding frame was applied to the remaining tran-
scripts, with super-ordinate themes identified on coding
completion. The NVIVO qualitative data program was
used for data entry, review and coding purposes.
Results
The final sample comprised 12 participants from across
eight disciplines [Table 1]. Mean interview length was
37.5 minutes [SD 11.3].
Thematic analysis
The thematic analysis revealed five themes about the
implementation of the clinical pathway, including: own-
ership; resources and responsibilities; education and
training; patient reluctance to access support; and inte-
gration with health services beyond oncology. Figure 1
was developed by the authors to demonstrate the inter-
connectedness and overlap of the themes as they emerged
from analysis of the participants’ quotes.
Theme A: Ownership of the pathway by the whole
cancer services team was the central theme of the study,
to enable the pathway to be acceptable to everyone
participating in its delivery. Ownership at the team level
was seen to foster the development of a whole team
approach directed towards a common goal and ensuring
that the pathway also reflected the team’s needs.
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priority, that they’re involved in shaping it, localizing
it, customizing it, that it reflects what they can do and
achieve, that they’re supported in it. …the pathway
document (is) a starting point and getting people
engaged in it.” (Psychiatrist 1)“…getting engagement with psychosocial services and
the nursing staff… is really important because the
bottom line is that at the end of the day they’re going
to implement it.” (Nurse – metro setting)
Ownership by cancer services leadership and hospital
management was thought to be essential (e.g. through
IT systems, policy, role descriptions) to ensure the path-
way was integrated into service delivery and that staff were
supported in delivering, monitoring and evaluating this
care.
“There needs to be explicit support from the institution
that spending time on these issues is time well spent.
That it’s valued and supported, people are given time
to do it, and that it is a priority…so that everyone’s
committed to trying to make it work… It needs
leadership, it needs major clinician leaders to be
supportive otherwise the screening won’t occur…”
(Psychiatrist 1)“…(it’s the) local champions that always makes a
difference.” (Psychiatrist 2)
Integration into existing hospital systems and docu-
mentation in the medical record where members of the
team could access this information was emphasised, so
that screening results could be used in meaningful ways.igure 1 Intersecting qualitative themes identified in the analysis.“…support should be at the system level in terms of how
it’s integrated, in routine documentation, in IT systems
and in quality review.” (Nurse clinician-researcher)“(we need the)…ability to track referrals and see
whether the patient actually saw the psycho-oncologist
because it doesn’t always happen… sometimes the
referral gets lost or someone forgets to make a phone
call, … and to have that in some sort of standardized,
accessible way, ideally as part of the medical record.”
(Medical oncologist)
Participants also reflected on the advantages of having
screening and pathway implementation incorporated
into policy, either at the local hospital or jurisdictional
level.
“And if… you’ve got senior buy-in to say ‘this is an ex-
pectation of our cancer services… if you provide the
support underneath that and the resourcing of the im-
plementation to a certain degree, you’re kind of cover-
ing both ends.” (Nurse – metro setting)
Theme B: Resources and responsibility for screening
and after care were viewed as two inter-related concepts.
For the resources required to implement a clinical path-
way, participants spoke about: a) the lack of staff time to
administer a screening tool and interpret the results,
and b) the lack of qualified psychosocial staff to provide
after-care for distressed patients. Lack of staff meant that
some participants expressed significant concerns about
not being able to provide care to those with the greatest
needs.
Participants reflected that from a ‘team’ perspective,
having a clinical pathway could provide resources that
would facilitate a more effective way of working together.
Most participants considered having to renegotiate or
make explicit the resources within the team to implement
a pathway was not an insurmountable barrier, but an issue
that requires careful planning and execution.
“… as a team… how are we going to address it and
can we address it, have we got the manpower to
actually follow through with it? So implementing I
think would take a bit of an effort but it’s not
impossible.” (Rural palliative care nurse)“…the two biggest problems are multiple points of
entry to the system, throughout the local health
district, and secondly is having the psycho-oncology
manpower to follow up on referrals.” (Social worker 1)
The concept of responsibility incorporates participant
concerns about duty of care or ethical responsibility for
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process. Participants were particularly concerned that
screening should not be introduced unless there was a clear
clinical pathway and staff with designated responsibilities
for each step of screening, interpreting results and ensuring
after-care to ensure distressed patients received the after
care they needed. Participants strongly emphasised that
screening was a means to an end and in isolation was
unlikely to result in improved patient outcomes.
“handing somebody something like the distress
thermometer and problem checklist is easy enough to
do… it’s who then goes on to deal with the results from
that?” (Psychologist 1)
There was a strong sense of responsibility for those with
greater levels of distress, and concern about the challenges
of helping such patients, and the need for health profes-
sional expertise to provide appropriate interventions.
“Some people do need more intense therapy to deal
with the problems that they’re going through… I would
like us to have psychiatric care available for… patients
with very severe distress or the complex ones. … if I
could get expert help with the diagnosis – I can
manage with more confidence… With things like some
of the behavioural therapies, you know, I don’t really
have time to give people that advice, it’s good to have
someone who can give that.” (Palliative care physician)
Participants noted that staff roles were often unclear,
and at times there were tensions around negotiating this
within the team. Developing a shared team understanding
of roles and responsibilities was considered an enabler to
assist referrals made to psychosocial team members.
“… I think that there needs to be some clarity around
who’s responsible for overseeing it across the patient’s
journey.” (Nurse clinician-researcher)“(there is) …a lack of clarity about who’s role it is, who
the decision maker is… It’s not that uncommon that
someone says ‘well that’s my role’ and everyone in the
rest of the team goes ‘is it?’” (Nurse metro setting)“…it is not just the access to the consultation liaison
services, or the psychosocial services, it’s actually also
having health professionals who are aware of this as
an issue and are prepared to refer.” (Psychiatrist 2)
Theme C: Education and training
Education was perceived as a core activity, to enable
identification of staff roles and responsibilities and build
ownership of the pathway. Key components of educationprograms included basic education about psychosocial
issues in cancer, how to use screening tools and the
clinical pathway for oncology health professionals,
communication skills training for staff in dealing with
distressed patients, as well as education for patients in
the importance and availability of psychosocial care.
“I think having everyone… involved in the education so
there’s ownership from the institution or from the
clinicians about it…” (Social worker 2)“widespread education that highlights… the
importance of psychosocial assessment, as well as the
efficacy of psychosocial intervention… delivered in
terms of… how it reduces clinician time by identifying
and intervening with psychological distress in a timely
manner, so you’re likely to reduce your face-to-face
time with a clinician which they’ll always like… and …
evidence about preventing unnecessary admissions and
presentations, as well as improving quality of life and
satisfaction with care.” (Social worker 1)
Presenting an evidence base and educating clinicians
about the benefits of screening for distress was also
noted by the three physician participants. This included
education for the whole team about the screening in-
strument, and the benefits of using it.
“You’d probably need to up-skill more than one person
so that if one person’s away other people could do it…
education gets past a lot of these barriers.” (Palliative
care physician)
One psychiatrist clearly articulated this when s/he said:
“we focus a great deal on changing clinicians’ expecta-
tions and skills, but I don’t think we’ve even tackled too
closely an understanding of what’s needed in order to
make services more acceptable to patients.”
Theme D: Patient reluctance
Participants spoke about the challenge of patient reluctance
to access psychosocial services; some patients are unaware
of available services, others are resistant to seeking assist-
ance because of stigma associated with mental illness. Par-
ticipants recounted that some patients will accept a referral
but not make an appointment, others value stoicism and
presenting a ‘brave face’. Whilst patient reluctance was
viewed as a significant barrier, participants thought it could
be overcome by sensitive and careful referral.
“For a lot of people, it’ll be the first time they’ve ever
spoken to someone about distress, so it’s not a simple
step… it needs to be done in a thoughtful and sensitive
way.” (Psychiatrist 1)
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(there’s) one gentleman at the moment who is just
refusing point blank to see anybody, yet his wife is
telling me that he’s spending most of his time in tears
at home and… mentioning one of the children’s names
he will just dissolve into tears, but we’re not actually
seeing him…” (Rural palliative care nurse)“…generally people don’t know what they’re entitled to,
what’s available, what the resources are.” (Social
worker 1)“…there needs also to be a degree of attention to the
stigma of mental health interventions among people
with cancer. .. a fairly high percentage of people who
decline services. We need some sort of educational
promotion program… to indicate that mental health
care is an integrated and important part of cancer
care.” (Psychiatrist 1)
Participants conveyed a sense of hopefulness that a
clinical pathway would go some way to ameliorating
patient reluctance. Thus, this theme intersects with the
themes of education and training, which would include
strategies to educate patients about the benefits of
psychosocial services, and with that of ownership, where
a whole team approach may work as an enabler to over-
come patient reluctance.
Theme E: Integration with health services beyond
oncology
In order for a clinical pathway to be successfully imple-
mented, participants considered there needs to be better
integration and communication across health services
including primary care, mental health, and the palliative
care services. This was particularly relevant when con-
sidering the referral of acutely distressed patients or
those with pre-existing conditions.
“… a lot of GPs… would like a more active role in the
acute treatment phase, better communication with the
cancer team, and …. the opportunity to have some
role in helping to support patients if they are suffering
distress, …given that we usually have a pre-existing
long-term relationship… and are well placed to be
able to provide some additional support.” (General
practitioner)
With regards to mental health services,
“Our mental health services are not all that good at
responding to people with physical illness. For people
who have pre-existing mental health problems who
develop cancer, where you need good partnershipbetween the systems, the mental health clinician needs to
stay involved and care for that person.” (Psychiatrist 1)
Similarly, with regards to palliative care services,
“Sometimes it’s difficult to know how much I can
attribute to cancer and how much is actually a
psychiatric disorder. Aged care psychiatry could be a
great help (but).. as soon as they see the word ‘cancer’
they just send them straight back (to palliative care)
and that’s a real problem.” (Palliative care physician)
Acceptability of a clinical pathway
Several participants talked about how a clinical pathway
could be acceptable in order to facilitate its implementa-
tion, including emphasising its benefits of supporting
evidence. Others noted that health professionals’ fatigue
from having to implement pathways in the clinical setting
(‘pathway fatigue’) would need to be overcome for
successful implementation.
“Clinical pathways are used in lots of different areas
and the ease at which it is to implement these things is
a challenge and… (there is a) degree of fatigue around
different things that get implemented… particularly
once you get down to department level.”
(Nurse – metro setting)“I think the biggest problem is actually producing data
that shows that this is beneficial, we know that what
we do can make a difference, we know that we can’t
squander scarce resources, we’ve just got to come up
with data to support that …. otherwise you’re not
going to get funding.” (Psychiatrist 2)“Someone needs to show that this will actually lead to
not necessarily a substantial increase in referrals to
the high end of the services, but actually a better
utilization of those resources.” (Nurse – metro setting).
Ultimately, participants in the study were generally
supportive of the framework, despite raising concerns and
describing potential barriers. As one psychologist said:
“…everybody agrees that routine screening should be
implemented (but nobody can decide how best to do it
or when it should be done or who’s going to be
responsible for it, or what you do with the information
once you get it) so having a document or a framework
like this is really useful.” (Psychologist 1)
Discussion
This qualitative paper identified five themes relating to
barriers and enablers that are likely to be encountered
Rankin et al. BMC Health Services Research  (2015) 15:28 Page 6 of 8during the implementation of a clinical pathway for anx-
iety and depression in cancer care. These intersecting
themes incorporate ownership; resources and respon-
sibility; education and training; patient reluctance; and
integration with health services beyond oncology. This is
the first study specific to a clinical pathway implemen-
tation in psychosocial oncology to formally document
such themes using a qualitative approach.
Strategies for successful distress screening implemen-
tation in cancer are frequently based on review articles,
commentary and lessons learned during attempts to im-
plement screening in Canada, the US and UK [5,26,27].
Our research significantly enhances the evidence base,
by identifying enabling strategies that integrate screen-
ing and after-care in cancer services. The identified
themes are consistent with those documented about
barriers and enablers to implementation of evidence
into practice more generally [28]. The ownership of a
clinical pathway by the whole cancer services team,
including leadership, was shown to be crucial to
successful implementation. The extant literature also
confirms the importance of being strategic, collabora-
tive and explicitly aware of the culture of health care
delivery [5,29] and engaging clinicians in the implemen-
tation process [27].
Lack of resources [time, finances, equipment and
skills] are well documented as significant barriers to
guideline implementation in chronic health conditions
[30-32], distress screening in cancer [33], and in organis-
ing psychosocial services [34]. Enabling strategies in-
clude using phased-in approaches to implementation,
using research and evaluation as support tools and part-
nering proactively with stakeholders [29]. Our findings
further suggest integrating clinical pathways into existing
hospital systems including cancer services policy and IT
systems, and for hospital leadership to endorse such
activities. Participants emphasised the ability to track
referrals and demonstrate outcomes to ensure high qual-
ity care and evaluate services.
The lack of education and training to accompany im-
plementation was identified as critical and has been
identified as a significant barrier to distress screening
also [8]. Our study also revealed that education was
considered to be significant enabler for successfully
implementing a clinical pathway. Participants empha-
sised the need for cancer services staff to understand
each other’s roles and responsibilities in order to inte-
grate processes for screening, referral and providing
after-care for patients.
Patient reluctance or refusal of treatment for distress
is another well documented barrier to care [10,35-37].
Although fewer participants in this study reflected on
patient reluctance, there was very strong support for
education for patients as a means to reducing the stigmaattached to mental health issues and referral. Openly
acknowledging resistance from patients and staff can fa-
cilitate greater acceptance of distress screening and
after-care [29].
This study contributes new findings about acknow-
ledging services outside of oncology that patients may
already utilise, particularly integration with mental health
services and existing relationships with the general
practitioner. To our knowledge, this aspect has not been
previously discussed in the literature, and yet is clearly
of considerable relevance.
Interpreting barriers and enablers within identified
themes
Barriers and enablers to implementation were evident
across all five themes. We found it interesting that
participants identified each theme as both a barrier and
enabler to implementation. For example, the absence of
education and training was perceived as a barrier, but
when included as a core implementation strategy it was
perceived as an enabler. Resources and responsibility
were strongly interpreted as barriers if not addressed;
yet improvements to organising resources were perceived
as an enabler. Ownership by the team was initially per-
ceived as a barrier, but as the interviews progressed,
many participants became more positive in their views
that an engaged team that was willing to shape and lead
pathway implementation could work cooperatively to
overcome known barriers. Participants clearly identi-
fied that demonstrating the efficacy and efficiency of an
evidence-based pathway – in more accurately identifying
anxiety and depression, reducing unplanned admissions
and clinician time in consultations – would facilitate
implementation.
The limitations of this study are considered to be the
small sample size and using a purposive sample, although
multi-disciplinary participant expertise and experience
with the local health system is advantageous, and thematic
saturation was achieved. We note that a larger sample
would be useful in identifying whether barriers and
enablers were perceived differently by medical, nursing
and allied health professionals, as well as by patients. In
order to address this limitation and building on the
current results, a Delphi process with a larger sample
has been undertaken to establish consensus about the
draft clinical pathway from a wider stakeholder group;
data analysis is in progress.
Conclusions
Our results demonstrate consensus among multi-
disciplinary experts that a draft clinical pathway has
the potential to enable screening for anxiety and
depression in cancer care that is not considered in
isolation from after-care and actively responding to
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as both barriers and enablers – provide a basis for a
future implementation plan that includes strategies to
overcome barriers and facilitate positive uptake. The
next steps are to design and deliver this clinical path-
way, addressing the context of each health service,
to ensure team ownership, endorsement by leaders,
education and training strategies for both patients and
health professionals, and the integration of the pathway
into existing cancer services.
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